About CVINJ

Established formally in 2001, the Cardiovascular Institute of New Jersey (CVINJ) provides research, education and patient care, bringing together clinicians and scientists working in collaboration across multiple disciplines.

The mission of the CVINJ is to translate new knowledge of heart disease into practical applications and improve heart health by:

• Developing and pioneering integrative strategies to prevent, treat and cure heart disease;
• Translating science and technology into new applications;
• Promoting heart health; and,
• Training future leaders in cardiovascular medicine.  

CVINJ is uniquely positioned to achieve this mission because of its outstanding clinical services, research, education and community outreach programs, its partnership with the Robert Wood Johnson University Hospital and its proximity to the many multinational pharmaceutical and medical device companies located in New Jersey.

CVINJ continues to achieve acknowledged prominence by building on its core strengths:

• Translational research, development and evaluation of new cardiovascular agents and devices;
• Nationwide, multi-center, clinical trials of new, safe and effective treatments for cardiovascular disease;
• Evidence-based clinical practice standards and clinical care policies utilizing data from its statewide cardiovascular disease database;
• Non-invasive techniques for diagnosing cardiovascular disease, using bioengineering methods; and,
• Pre-eminent award-winning faculty.